Avricore Health CEO Hector Bremner joined Steve Darling from Proactive to share news about the company's collaboration with Ascensia Diabetes Care, a global diabetes care company and a subsidiary of PHC Holdings Corporation.
Avricore Health has entered into an agreement with Ascensia Diabetes Care to integrate their blood glucose monitoring systems, known as CONTOURNEXT GEN and CONTOURNEXT ONE, with Avricore's pharmacy-based point-of-care testing platform, HealthTab.
Bremner explained that this collaboration aims to provide better support to pharmacists in Canada to help them manage diabetes more effectively. By linking the daily blood glucose testing results and pattern history data collected via the CONTOURNEXT GEN or CONTOURNEXT ONE meter that the patient uses to the patient's HealthTab account, pharmacists will have access to valuable data insights for better patient care.
The partnership also includes discussions on collaborative communications to ensure patients and pharmacists can take full advantage of the data insights offered by both technologies. The goal is to enhance patient engagement and improve diabetes management through the seamless integration of the blood glucose monitoring systems and HealthTab.
View source version on newsdirect.com: https://newsdirect.com/news/avricore-health-announces-company-will-add-blood-glucose-meters-to-healthtab-platform-251044938
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Daily Scotland News journalist was involved in the writing and production of this article.